ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Range Cancer Therapeutics ETF
9.02
0.0000
成交量:
- -
成交額:
- -
市值:
704.29萬
市盈率:
23.74
高:
9.02
開:
9.02
低:
9.02
收:
9.02
52周最高:
9.02
52周最低:
9.02
股本:
78.08萬
流通股本:
78.08萬
量比:
- -
換手率:
- -
股息:
0.00
股息率:
0.01%
每股收益(TTM):
0.3800
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
中國科學家研發電刺激生髮梳:結合基因療法28天恢復小鼠近100%毛髮
IT之家
·
11/11
腫瘤治療:靶向與疫苗雙線加速
经济参考报
·
11/04
BNCT複發性腦膜瘤適應證海外正式獲批:中國生物科技服務(08037)旗下鵬博海南醫院打開顱內腫瘤治療新空間
智通财经
·
11/02
ARTIVA BIOTHERAPEUTICS 公司盤前股價下跌 30%;在兩名患者死亡後,公司停止細胞療法,裁員 94%
智通财经
·
10/27
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/CNCR"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNCR\",,,,,undefined,":{"symbol":"CNCR","market":"US","secType":"STK","nameCN":"Range Cancer Therapeutics ETF","latestPrice":9.02,"timestamp":1795208400000,"preClose":9.02,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":780814,"shares":780814,"eps":0.38,"marketStatus":"休市中","change":0,"latestTime":"11-20 16:00:00 EST","open":9.02,"high":9.02,"low":9.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.38,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.02,"sharesOutstanding":780814,"nav":8.9,"aum":6949244.6,"dividendRate":0.000111,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNCR\",,,,,undefined,":{"symbol":"CNCR","floatShares":780814,"roa":"--","roe":"--","lyrEps":0,"shares":780814,"dividePrice":0.001,"high":9.02,"amplitude":0,"preClose":9.02,"low":9.02,"week52Low":9.02,"pbRate":"--","week52High":9.02,"institutionHeld":0,"latestPrice":9.02,"eps":0.38,"divideRate":0.000111,"volume":0,"delay":0,"ttmEps":0.38,"open":9.02,"prevYearClose":9.02,"prevWeekClose":9.02,"prevMonthClose":9.02,"prevQuarterClose":9.02,"fiveDayClose":9.02,"twentyDayClose":9.02,"sixtyDayClose":9.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-28","symbol":"CNCR","reason":null,"defaultRemindTime":1748439000000,"announcedDate":"2025-05-27","type":"delisting","dateTimestamp":1748404800000},{"market":"US","date":"2021-12-29","symbol":"CNCR","amount":1.8533352,"defaultRemindTime":1640788200000,"name":"Loncar Cancer Immunotherapy ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-30","symbol":"CNCR","amount":0.2881193,"name":"Loncar Cancer Immunotherapy ETF","recordDate":"2021-01-04","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNCR\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-04","value":0.2881193,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":1.8533352,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNCR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNCR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2682039233","title":"中國科學家研發電刺激生髮梳:結合基因療法28天恢復小鼠近100%毛髮","url":"https://stock-news.laohu8.com/highlight/detail?id=2682039233","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682039233?lang=zh_tw&edition=fundamental","pubTime":"2026-11-11 14:59","pubTimestamp":1794380365,"startTime":"0","endTime":"0","summary":"IT之家 11 月 11 日消息,中国北京航空航天大学、香港城市大学等机构的研究人员开发出一种名为 Detangle 的电刺激生发梳,能够利用电脉冲将治疗性遗传物质输送至毛囊深处,同时激活与毛发生长有关的生物信号通路。在小鼠实验中,研究人员每三天使用一次,持续 28 天后,小鼠实验区域的毛发覆盖率接近 100%,高于每天使用米诺地尔的小鼠实验组。相关成果尚未证明该装置对人类雄激素性脱发具有同等效果,其人体使用效果和长期安全性也有待进一步验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8xxRNES6f6c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680779427","title":"腫瘤治療:靶向與疫苗雙線加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2680779427","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680779427?lang=zh_tw&edition=fundamental","pubTime":"2026-11-04 05:02","pubTimestamp":1793739777,"startTime":"0","endTime":"0","summary":"今年以来,国内已有超30款肿瘤创新药获批,靶向药持续补齐KRASG12C、EGFR20ins、NTRK、FGFR、MET等既往难治的靶点,靶向治疗可及性不断提高。与此同时,肿瘤疫苗赛道同步提速。业内认为,靶向药靶点验证成熟,已进入商业化与同质化竞争阶段;肿瘤疫苗尚处前沿探索、临床验证阶段。行业看好二者协同:靶向药缩瘤同时,肿瘤疫苗通过主动免疫机制,联合用药提高治疗效果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611043920679496.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611043920679496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1209","LU0329678337.USD","CANC","LU0737861772.HKD","BK1583","CNCR","06078","LU0329678170.USD","LU2488822045.USD","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680578642","title":"BNCT複發性腦膜瘤適應證海外正式獲批:中國生物科技服務(08037)旗下鵬博海南醫院打開顱內腫瘤治療新空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2680578642","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680578642?lang=zh_tw&edition=fundamental","pubTime":"2026-11-02 09:12","pubTimestamp":1793581921,"startTime":"0","endTime":"0","summary":"中国生物科技服务控股有限公司合作的海外BNCT治疗系统NeuCure于10月28日已获海外监管机构正式批准新增“复发性脑膜瘤”适应证。此次正式获批,标志着BNCT的临床应用边界由现有头颈部肿瘤正式拓展至颅内肿瘤赛道,为临床处理棘手的复发性脑膜瘤提供了全新的精准治疗选择,也为中国生物科技服务旗下鹏博(海南)硼中子医院打开了明确的增量患者空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CANC","BK1219","LU0329678337.USD","BK1209","08037","LU0329678170.USD","BK1583","CNCR","BK1511","LU0737861772.HKD","LU2488822045.USD","06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678863177","title":"ARTIVA BIOTHERAPEUTICS 公司盤前股價下跌 30%;在兩名患者死亡後,公司停止細胞療法,裁員 94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678863177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678863177?lang=zh_tw&edition=fundamental","pubTime":"2026-10-27 20:18","pubTimestamp":1793103525,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR","WDNA","SYNB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CNCR\",params:#limit:6,delay:false,,,undefined,":[]}}